Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 3 1

Status

Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Carboplatin 106 Cisplatin 97 Paclitaxel 78 pembrolizumab 69 Gemcitabine 59 Pemetrexed 49 Cyclophosphamide 46 Docetaxel 45 Dexamethasone 45 durvalumab 44 Capecitabine 44 Radiotherapy 40 Nivolumab 37 Lenalidomide 37 Specimen Handling 36 Doxorubicin 36 Rituximab 34 Oxaliplatin 34 Bevacizumab 33 Magnetic Resonance Spectroscopy 32 Fluorouracil 32 atezolizumab 29 Etoposide 29 Vincristine 26 Radiation 26 Leucovorin 26 Letrozole 24 Bortezomib 24 Fulvestrant 23 Prednisone 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × epigallocatechin gallate × Clear all

NCT05364008 2026-03-23

FRIEND

Yale University

Phase 3 Active not recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡